These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 11075396)

  • 1. [Value of anti-TNF-alpha molecules in inflammatory and infectious diseases].
    Fautrel B; Cherin P
    Rev Med Interne; 2000 Oct; 21(10):872-88. PubMed ID: 11075396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned?
    Feldmann M; Maini RN
    Annu Rev Immunol; 2001; 19():163-96. PubMed ID: 11244034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antitumor necrosis factor therapy for inflammatory bowel disease: a review of agents, pharmacology, clinical results, and safety.
    Sandborn WJ; Hanauer SB
    Inflamm Bowel Dis; 1999 May; 5(2):119-33. PubMed ID: 10338381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Role of anti-TNF therapy in rheumatoid arthritis].
    Meyer O
    Presse Med; 2000 Mar; 29(9):463-8. PubMed ID: 10745935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of rheumatoid arthritis by inhibition of tumor necrosis factor with infliximab or etanercept].
    Tijhuis GJ; van de Putte LB; Breedveld FC
    Ned Tijdschr Geneeskd; 2001 Sep; 145(39):1880-5. PubMed ID: 11605312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Inhibitors of TNFalpha].
    Brousse C
    Rev Med Interne; 2003 Feb; 24(2):123-6. PubMed ID: 12650894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-TNF alpha therapy is useful in rheumatoid arthritis and Crohn's disease: analysis of the mechanism of action predicts utility in other diseases.
    Feldman M; Taylor P; Paleolog E; Brennan FM; Maini RN
    Transplant Proc; 1998 Dec; 30(8):4126-7. PubMed ID: 9865320
    [No Abstract]   [Full Text] [Related]  

  • 8. Transcending conventional therapies: the role of biologic and other novel therapies.
    Sandborn WJ
    Inflamm Bowel Dis; 2001 May; 7 Suppl 1():S9-16. PubMed ID: 11380043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Anti-TNF alpha in rheumatoid arthritis].
    Schreiber S; Sternon J
    Rev Med Brux; 2001 Jun; 22(3):174-80. PubMed ID: 11488086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TNF-alpha-targeted therapy in rheumatoid arthritis.
    Wendling D; Toussirot E
    Rev Rhum Engl Ed; 1999 Apr; 66(4):187-91. PubMed ID: 10339773
    [No Abstract]   [Full Text] [Related]  

  • 11. Biological insights from clinical trials with anti-TNF therapy.
    Feldmann M; Charles P; Taylor P; Maini RN
    Springer Semin Immunopathol; 1998; 20(1-2):211-28. PubMed ID: 9836378
    [No Abstract]   [Full Text] [Related]  

  • 12. TNF inhibitors: a new age in rheumatoid arthritis treatment.
    Anderson DL
    Am J Nurs; 2004 Feb; 104(2):60-8; quiz 68-9. PubMed ID: 14767382
    [No Abstract]   [Full Text] [Related]  

  • 13. Optimizing anti-tumor necrosis factor strategies in inflammatory bowel disease.
    Sandborn WJ
    Curr Gastroenterol Rep; 2003 Dec; 5(6):501-5. PubMed ID: 14602060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TNF alpha inhibitors in the treatment of psoriasis and psoriatic arthritis.
    Tobin AM; Kirby B
    BioDrugs; 2005; 19(1):47-57. PubMed ID: 15691217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of inflammatory bowel disease during anti-TNF-α therapy for inflammatory rheumatic disease: a nationwide series.
    Toussirot É; Houvenagel É; Goëb V; Fouache D; Martin A; Le Dantec P; Dernis E; Wendling D; Ansemant T; Berthelot JM; Bader-Meunier B; Kantelip B;
    Joint Bone Spine; 2012 Oct; 79(5):457-63. PubMed ID: 22088934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Copernican revolution in the therapy of rheumatoid arthritis: the contribution of anti-TNFalpha drugs].
    Bombardieri S; Ferraccioli G; Ferri C; Galeazzi M; Lapadula G; Cerinic MM; Montecucco C; Triolo G; Trotta F; Valentini G
    Reumatismo; 2009; 61 Suppl 1():1-23. PubMed ID: 19999184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological and clinical effects of anti-TNFalpha treatment.
    Valesini G; Iannuccelli C; Marocchi E; Pascoli L; Scalzi V; Di Franco M
    Autoimmun Rev; 2007 Nov; 7(1):35-41. PubMed ID: 17967723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TNF-alpha inhibition: the need for a tumor necrosis factor thermostat.
    O'Dell JR
    Mayo Clin Proc; 2001 Jun; 76(6):573-5. PubMed ID: 11393494
    [No Abstract]   [Full Text] [Related]  

  • 19. Risk of herpes zoster in patients with rheumatoid arthritis treated with anti-TNF-alpha agents.
    Strangfeld A; Listing J; Herzer P; Liebhaber A; Rockwitz K; Richter C; Zink A
    JAMA; 2009 Feb; 301(7):737-44. PubMed ID: 19224750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of tumor necrosis factor blockade on the response to pneumococcal vaccination in patients with rheumatoid arthritis and ankylosing spondylitis.
    Elkayam O; Caspi D; Reitblatt T; Charboneau D; Rubins JB
    Semin Arthritis Rheum; 2004 Feb; 33(4):283-8. PubMed ID: 14978666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.